for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Chemed Corporation

CHE

Latest Trade

480.36USD

Change

-4.42(-0.91%)

Volume

46,555

Today's Range

479.68

 - 

493.68

52 Week Range

330.01

 - 

528.29

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
484.78
Open
489.30
Volume
46,555
3M AVG Volume
1.63
Today's High
493.68
Today's Low
479.68
52 Week High
528.29
52 Week Low
330.01
Shares Out (MIL)
15.84
Market Cap (MIL)
7,621.79
Forward P/E
29.29
Dividend (Yield %)
0.28

Next Event

Q3 2020 Chemed Corp Earnings Release

Latest Developments

More

Chemed Q2 Adjusted Earnings Per Share $4.41

Chemed Corp Q1 Revenue Rose 11.6% to $516 Million

Chemed Corporation’S Board Of Directors Authorizes An Additional $250 Million For Stock Repurchase

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Chemed Corporation

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry

Healthcare Facilities

Contact Info

255 E 5th St Ste 2600

CINCINNATI, OH

45202-4138

United States

+1.513.7626690

http://www.chemed.com

Executive Leadership

George J. Walsh

Independent Chairman of the Board

Kevin J. McNamara

President, Chief Executive Officer, Director

David Patrick Williams

Chief Financial Officer, Executive Vice President

Spencer S. Lee

Executive Vice President

Nicholas Michael Westfall

Executive Vice President

Key Stats

1.33 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

1.7K

2018

1.8K

2019

1.9K

2020(E)

2.1K
EPS (USD)

2017

8.430

2018

11.930

2019

13.950

2020(E)

16.347
Price To Earnings (TTM)
30.08
Price To Sales (TTM)
3.77
Price To Book (MRQ)
10.10
Price To Cash Flow (TTM)
24.18
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
28.49
Return on Equity (TTM)
22.01

Latest News

Latest News

BRIEF-Chemed Corp Q1 Revenue Rose 11.6% to $516 Million

* Q1 EARNINGS PER SHARE ESTIMATE $3.65 -- REFINITIV IBES DATA

BRIEF-Chemed Says Unit Received $80.2 Mln From The Provider Relief Fund

* CHEMED CORP - ON APRIL 10, VITAS HEALTHCARE, UNIT OF CO RECEIVED $80.2 MILLION FROM U.S. FEDERAL GOVERNMENT FROM THE PROVIDER RELIEF FUND Source text: (http://www.sec.gov/archives/edgar/data/19584/000001958420000013/0000019584-20-000013-index.htm ) Further company coverage...

BRIEF-Chemed Corporation’S Board Of Directors Authorizes An Additional $250 Million For Stock Repurchase

* CHEMED CORPORATION’S BOARD OF DIRECTORS AUTHORIZES AN ADDITIONAL $250 MILLION FOR STOCK REPURCHASE

BRIEF-Chemed Reports Q4 Adjusted Earnings Per Share $4.22

* Q4 REVENUE $522 MILLION VERSUS REFINITIV IBES ESTIMATE OF $524.2 MILLION

BRIEF-Chemed Corp Q1 GAAP Earnings Per Share $2.66

* Q1 EARNINGS PER SHARE VIEW $2.36 -- THOMSON REUTERS I/B/E/S

BRIEF-Chemed Corp Says CEO Kevin McNamara's FY 2017 Total Compensation Was $7.9 Mln

* CHEMED CORP SAYS PRESIDENT AND CEO KEVIN MCNAMARA'S FY 2017 TOTAL COMPENSATION WAS $7.9 MLN VS $6.5 MLN IN FY 2016 - SEC FILING Source text: (http://bit.ly/2Hstd1Z) Further company coverage:

BRIEF-Chemed Corporation’s Board Authorizes Additional $150 Million For Stock Repurchase

* CHEMED CORPORATION’S BOARD OF DIRECTORS AUTHORIZES AN ADDITIONAL $150 MILLION FOR STOCK REPURCHASE

BRIEF-Chemed Q4 GAAP Earnings Per Share $3.25

* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $10.60 TO $10.85 EXCLUDING ITEMS

BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013​

* Chemed - Reached final agreement to end civil litigation and false claims act brought by U.S. Department of Justice in May 2013

Chemed to pay $75 million over false claims lawsuit: Justice Dept

Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

BRIEF-Chemed reports Q3 earnings per share $2.13

* Sees FY 2017 adjusted earnings per share $8.35 to $8.40 excluding items

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up